Claim(permalink)
Epidemiologista do Instituto Sabin de Washington diz que Coronavac do Butantan tem 49% de eficácia e não pode ser aprovada.
✓aos-fatos rating: not credible; published on 2021-01-15
Factors
veracity
not credible
Political Leaning
left political leaning
Sentiment
neutral sentiment
Date published
2021-01-15
Entities
MarsInstituto ButantanNone of the aboveBeleriandSinovac BiotechAntes (people)University of WashingtonVeja SneakersFederal Insurance Contributions Act taxVillageTaxonParvatiTempoSido (rapper)TER OccitanieMinute and second of arcPela (band)TwitterTransmission electron microscopyComoFacebookGarrett P.I.